Processa Pharmaceuticals

PCSA

Capitalización de mercado USD 5.28 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
1	1 Vanguard Group Malvern, Pennsylvania	USD 1.05 M	–	–	–
2	ACM 2 AIGH Capital Management Baltimore, Maryland	USD 853 k	–	–	–
3	3 Worth Venture Partners Fort Lee, New Jersey	USD 251 k	–	–	–
4	4 Geode Capital Management Boston, Massachusetts	USD 182 k	–	–	–
5	5 Verdence Capital Advisors Hunt Valley, Maryland	USD 168 k	–	–	–
6	6 Coastal Bridge Advisors Westport, Connecticut	USD 148 k	+USD 54.8 k	+40	+62%
7	7 Morgan Stanley New York	USD 138 k	+USD 134 k	+98	Nuevas
8	8 Janney Montgomery Scott Philadelphia, Pennsylvania	USD 135 k	–	–	–
9	9 State Street Boston, Massachusetts	USD 120 k	+USD 4.11 k	+3	+4%
10	10 BlackRock New York	USD 81 k	-USD 1.37 k	-1	-2%
11	11 Northern Trust Chicago, Illinois	USD 43 k	–	–	–
12	12 Renaissance Technologies New York	USD 33 k	+USD 31.5 k	+23	Nuevas
13	13 Vectors Research Management New York	USD 11 k	+USD 11 k	+8	Nuevas
14	14 Wells Fargo San Francisco, California	USD 9 k	–	–	–
15	15 Essex Investment Management Boston, Massachusetts	USD 6 k	+USD 6.85 k	+5	Nuevas
16	16 Allworth Financial Folsom, California	USD 5 k	–	–	–
17	17 Tower Research Capital (TRC) New York	USD 4 k	-USD 4.11 k	-3	-50%
18	18 Royal Bank of Canada Toronto, Ontario, Canada	USD 3 k	–	–	–
19	19 Solas Capital Management Darien, Connecticut	–	-USD 69 k	-46	Cerradas
20	20 UBS Group Zurich, Switzerland	–	-USD 3 k	-2	Cerradas